A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with JIA are at risk of inflammation of the uvea in the eye (uveitis). Overall, 20% to 25% of paediatric uveitis is associated with JIA. Major risk factors for development of uveitis in JIA are...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanan, Athimalaipet V, Dick, Andrew D, Benton, Diana, Compeyrot-Lacassagne, Sandrine, Dawoud, Dalia, Hardwick, Ben, Hickey, Helen, Hughes, Dyfrig, Jones, Ashley, Woo, Patricia, Edelsten, Clive, Beresford, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892031/
https://www.ncbi.nlm.nih.gov/pubmed/24405833
http://dx.doi.org/10.1186/1745-6215-15-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892031/
https://www.ncbi.nlm.nih.gov/pubmed/24405833
http://dx.doi.org/10.1186/1745-6215-15-14

Ejemplares similares